SB-328437
SB-328437 is a potent, selective non-peptide CCR3 antagonist with an IC50 of 4.5 nM. SB-328437 can inhibit eosinophil migration induced by eotaxin, eotaxin-2, and monocyte chemotactic protein-4. In addition, SB-328437 can sensitize 5-FU -resistant gastric cancer cells. SB-328437 can also reduce the recruitment of neutrophils to the lungs and pulmonary inflammation during acute inflammation. SB-328437 can be used in the research of inflammation-related diseases[1][2][3].
Product Specifications
CAS Number
247580-43-4
UNSPSC
12352005
Hazard Statement
H302, H400
Target
CCR; Thymidylate Synthase
Type
Reference compound
Related Pathways
Apoptosis; GPCR/G Protein; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/sb-328437.html
Purity
99.58
Solubility
DMSO : 87.5 mg/mL (ultrasonic)
Smiles
O=C(OC)[C@H](CC1=CC=C([N+]([O-])=O)C=C1)NC(C2=C3C=CC=CC3=CC=C2)=O
Molecular Formula
C21H18N2O5
Molecular Weight
378.38
Precautions
H302, H400
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CCR3
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mouse PINP (Procollagen Type I N-Terminal Propeptide) CLIA Kit
Mouse PINP (Procollagen Type I N-Terminal Propeptide) CLIA Kit
Mouse PINP (Procollagen Type I N-Terminal Propeptide) CLIA Kit
